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Topic/Research Goal 
- Botulinum toxin type A injections offers a 
treatment option that could be more 
effective than traditional treatment and 
less invasive than surgical replacement
- Can Botox be the cure for TMJ associated 
pain and dysfunction? 
2https://www.southlakestyle.com/style/botox-injections-can-help-treat-pain-caused-by-tmj/
Background - 70-80% of the population
- conservative treatment meant for short-term 
use 
- Surgical replacement of jaw joints is highly 
controversial and has inconclusive efficacy
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https://www.tmjtreatmentcentersofwi.com/temporomandibular-disorders
- Botulinum toxin type A known to be the most 
effective therapy and patient-friendly
- Botulinum toxin type A injections, or botox, offers 
an alternative treatment that could be more 
effective than conservative treatment options 









- Articles from 2016 to present 
- Search terms: botox, botulinum toxin type a, tmj 
disorders, tmj dysfunction, bruxism, masseter 
muscle, muscular relaxation, tension 
headaches, and masticatory muscles
- patient-reported outcomes based on pain 
reduction and/or improvement in function of the 
temporomandibular joint
- Studies evaluating the potential side effects of 
Botox were completed by treating and 
observing mice.
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-Prospective outcome study 
-men and women between the ages of 19 and 48
-21 mice units (MU) of botulinum toxin type A 
injections in both masseter bellies
-visual analogue scale (VAS) and verbal 
numerical rating scale (VNRS). 
Results showed a significant decrease in VAS 
and VNRS values following the treatment, 





- prospective study 
- 40 MPS patients 
Botulinum Toxin Type A 
Injections (Group 1, n=20) or dry 
needling (Group 2, n=20) 
- There were significant pain relief 
and functional improvement after 
treatment in both groups. 
(p=0.002)
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- retrospective review 
- 55 of the 71 participants, or 77% reported 
beneficial effects from the treatment.
- less improvement if the time between the initial 
Botox injection and follow-up was less than an 
average of 5 weeks compared to an average 
follow-up of 5-10 weeks (P=0.009)
- Overall, patients reported less improvement 
and pain reduction as the time between follow-
up and initial injection increased.
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-A controlled trial 
-30 subjects were split into two even groups
receiving saline injections (Group 1, n=15) or 
botulinum toxin type A injections (Group 2, n=15) into 
each masseter muscle
-The injection decreased the peak amplitude of EMG 
bursts during sleep bruxism only in the treatment 
group for 12 weeks. (p < 0.0001)
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Figure 2. The change of amplitude of EMG burst 
in the masseter muscle during MVC (A) and 
RMMA (B). Graphs show significant time and 
group interactions. The amplitude of EMG burst in 
the masseter muscle during MVC and RMMA 
significantly decreased only in the treatment group 
for 12 weeks. MVC, maximal voluntary clenching; 
RMMA, rhythmic masticatory muscle activity.
-Adult mice were divided into an untreated 
control group and an experimental group, 
with the experimental group receiving one 
single botulinum toxin injection into the right 
masseter and saline into the left masseter.
-Mice injected with botulinum toxin showed 
significant bone loss and shape changes in 
their right condyles. (P-value <0.001)
- Botulinum toxin was injected into the right 
masseter of six mice
- Experimental and control mice were killed 
four and eight weeks after the 
experimental group received the injection.
- Results showed that bone volume fraction 
was significantly decreased on the 
subchondral bone of the botox-injected 
side of the experimental group mice. 
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Conflicting Conclusion -Cohort study was done that included 79 women with 
temporomandibular joint 
disorders (TMJD) affecting 
their facial muscles
-35 received Botox 
injections and 44 who were 
not treated with Botox
-the study showed 
botulinum toxin injections 
does not affect the density 
of the jaw bone and 






- botulinum toxin A proven to be an effective 
alternative to conservative treatment options 
commonly used to treat pain and discomfort 
associated with temporomandibular joint 
disorders
- The potentially harmful effect of bone loss after 
long-term use of this treatment method must be 
further investigated and researched on a larger 
scale. 
- Further studies must be done to conclude just 
how long the positive side effects last and when 
treatment must be completed to ensure the 
treatment is financially feasible and practical.  
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Conclusion The effectiveness of botulinum 
toxin type A injections for treatment of 
symptoms associated with 
temporomandibular joint disorders is 
proven to be effective. Further 
research must be conducted in order to 
ensure clinical safety, specifically with 
long-term use of this treatment 
method, as well as to determine the 
duration required between doses in 
order to effectively treat the symptoms 
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